185 related articles for article (PubMed ID: 8178343)
1. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation.
Mueller EA; Kovarik JM; van Bree JB; Lison AE; Kutz K
Transplantation; 1994 Apr; 57(8):1178-82. PubMed ID: 8178343
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients.
Kovarik JM; Mueller EA; van Bree JB; Flückiger SS; Lange H; Schmidt B; Boesken WH; Lison AE; Kutz K
Transplantation; 1994 Sep; 58(6):658-63. PubMed ID: 7940685
[TBL] [Abstract][Full Text] [Related]
3. Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients.
Kovarik JM; Mueller EA; van Bree JB; Arns W; Renner E; Kutz K
Ther Drug Monit; 1994 Jun; 16(3):232-7. PubMed ID: 8085277
[TBL] [Abstract][Full Text] [Related]
4. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
Frei UA; Neumayer HH; Buchholz B; Niese D; Mueller EA
Transplantation; 1998 Jun; 65(11):1455-60. PubMed ID: 9645802
[TBL] [Abstract][Full Text] [Related]
6. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
7. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation.
Kovarik JM; Vernillet L; Mueller EA; Freiburghaus R; Niederberger W; Kutz K
Ther Drug Monit; 1994 Oct; 16(5):519-25. PubMed ID: 7846753
[TBL] [Abstract][Full Text] [Related]
9. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
Trull A; Steel L; Sharples L; Stewart S; Parameshwar J; McNeil K; Wallwork J
Ther Drug Monit; 1999 Feb; 21(1):17-26. PubMed ID: 10051050
[TBL] [Abstract][Full Text] [Related]
10. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the pharmacokinetics of cyclosporine in patients following long-term administration after a kidney transplant: comparison of Neoral and Sandimmune.
Takahara S; Ichimaru N; Kojima Y; Namba Y; Toki K; Shi Y; Yoshimura K; Matsumiya K; Nonomura N; Okuyama A
Transplant Proc; 2004 Mar; 36(2 Suppl):456S-460S. PubMed ID: 15041387
[TBL] [Abstract][Full Text] [Related]
12. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
White M; Pelletier GB; Tan A; Jesina C; Carrier M
J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
van Mourik ID; Thomson M; Kelly DA
Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors.
Akhlaghi F; Keogh AM; McLachlan AJ; Kaan A
J Heart Lung Transplant; 2001 Apr; 20(4):431-8. PubMed ID: 11295581
[TBL] [Abstract][Full Text] [Related]
16. Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation.
Roza A; Tomlanovich S; Merion R; Pollak R; Wright F; Rajagopalan P; Pruett T; Scandling J; Ryan J; Awni W; Schweitzer S; Greco R; Lam W; Nabulsi A; Hoffman R
Transplantation; 2002 Oct; 74(7):1013-7. PubMed ID: 12394847
[TBL] [Abstract][Full Text] [Related]
17. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.
Keown P; Landsberg D; Halloran P; Shoker A; Rush D; Jeffery J; Russell D; Stiller C; Muirhead N; Cole E; Paul L; Zaltzman J; Loertscher R; Daloze P; Dandavino R; Boucher A; Handa P; Lawen J; Belitsky P; Parfrey P
Transplantation; 1996 Dec; 62(12):1744-52. PubMed ID: 8990355
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
Barone G; Chang CT; Choc MG; Klein JB; Marsh CL; Meligeni JA; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
Transplantation; 1996 Mar; 61(6):875-80. PubMed ID: 8623152
[TBL] [Abstract][Full Text] [Related]
19. Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral.
Mendez R; Abboud H; Burdick J; Copley B; Freeman R; Batiuk TD; Cooney GF; Barbeito R
Clin Ther; 1999 Jan; 21(1):160-71. PubMed ID: 10090433
[TBL] [Abstract][Full Text] [Related]
20. Concentration-guided strategies in drug development: experience with a cyclosporine analog in transplantation.
Kovarik JM; Mueller EA; Kallay Z; Smith HT; Lison AE; Arns W; Renner E
J Clin Pharmacol; 1995 Dec; 35(12):1136-43. PubMed ID: 8750363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
